Amgen
AMGN
2,502 hedge funds and large institutions have $108B invested in Amgen in 2022 Q4 according to their latest regulatory filings, with 314 funds opening new positions, 846 increasing their positions, 1,007 reducing their positions, and 87 closing their positions.
261% more first-time investments, than exits
New positions opened: 314 | Existing positions closed: 87
17% more capital invested
Capital invested by funds: $92.3B → $108B (+$16B)
16% more funds holding in top 10
Funds holding in top 10: 85 → 99 (+14)
8% more funds holding
Funds holding: 2,323 → 2,502 (+179)
2% more call options, than puts
Call options by funds: $1.45B | Put options by funds: $1.42B
0.51% less ownership
Funds ownership: 76.67% → 76.16% (-0.51%)
16% less repeat investments, than reductions
Existing positions increased: 846 | Existing positions reduced: 1,007
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$609M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$484M |
| 3 |
BlackRock
New York
|
+$441M |
| 4 |
Morgan Stanley
New York
|
+$408M |
| 5 |
Renaissance Technologies
New York
|
+$261M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$1.68B |
| 2 |
UBS AM
Chicago,
Illinois
|
-$759M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$503M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$470M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$234M |
AMGN Hedge Fund Activity: Q4 2022 in Review
2,502 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2022, worth a combined $108B — up 17% from $92.3B a quarter earlier.
Buyers outnumbered sellers: 314 funds opened new AMGN positions and 87 closed out — a net gain of 227 holders — while 846 added to existing stakes and 1,007 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $609M. The largest seller was Goldman Sachs, cutting an estimated $1.68B.
- 2,502 institutional investors held Amgen (AMGN) as of Q4 2022, up from 2,323 in Q3 2022.
- Funds reported $108B of Amgen stock for Q4 2022, up 17% quarter-over-quarter.
- 314 funds opened new Amgen positions in Q4 2022 and 87 closed out, a net change of +227 holders.
- The largest Amgen buyer in Q4 2022 was JP Morgan Chase, an estimated $609M added.
- The largest Amgen seller in Q4 2022 was Goldman Sachs, an estimated $1.68B sold.
Based on aggregated 13F filings for Q4 2022.